GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Illumina, Inc. (ILMN) [hlAlert]

Rating:
Buy ILMN
up 31.39 %

Illumina, Inc. (ILMN) upgraded to Buy with price target $205 by Maxim Group

Posted on: Wednesday,  Apr 23, 2014  12:00 AM ET by Maxim Group

Maxim Group rated Buy Illumina, Inc. (NASDAQ: ILMN) on 04/23/2014, when the stock price was $153.69. Since
then, Illumina, Inc. has gained 31.39% as of 01/26/2016's recent price of $201.94.
If you would have followed this Maxim Group's recommendation on ILMN, you would have gained 31.39% of your investment in 643 days.

Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company?s subsidiary is Solexa, Inc.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/23/2014 12:00 AM Buy
None
153.69 205.00
as of 10/17/2014
1 Week up  7.14 %
1 Month down  -6.83 %
3 Months down  -0.75 %
1 YTD up  7.30 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2011 9:25 AM Hold
None
26.04
6/21/2011 8:25 AM Buy
None
72.64 87.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy